Authors: MIGNOTTE H LASSET C BONADONA V

Citation: H. Mignotte et al., IATROGENIC RISKS OF ENDOMETRIAL CARCINOMA AFTER TREATMENT FOR BREAST-CANCER IN A LARGE FRENCH CASE-CONTROL STUDY, European journal of cancer, 34, 1998, pp. 46-47

Authors: LASSET C MIGNOTTE H BONADONA V CHAUVIN F

Citation: C. Lasset et al., PROGNOSIS OF TAMOXIFEN-ASSOCIATED ENDOMETRIAL CANCER, Journal of clinical oncology, 16(7), 1998, pp. 2573-2573

Authors: LASSET C BONADONA V CHAUVIN F MIGNOTTE H BREMOND A

Citation: C. Lasset et al., RISK OF ENDOMETRIAL CANCER IN PREMENOPAUSAL WOMEN ON TAMOXIFEN, Lancet, 352(9138), 1998, pp. 1476-1476

Authors: MIGNOTTE H LASSET C BONADONA V LESUR A LUPORSI E RODIER JF CUTULI B LASRY S MAURIAC L GRANON C KERR C GIARD S HILL C DELAFONTAN B DEGISLAIN C DANJOU J FONDRINIER E LEFEUVRE C PARACHE RM CHAUVIN F

Citation: H. Mignotte et al., IATROGENIC RISKS OF ENDOMETRIAL CARCINOMA AFTER TREATMENT FOR BREAST-CANCER IN A LARGE FRENCH CASE-CONTROL STUDY, International journal of cancer, 76(3), 1998, pp. 325-330

Authors: MIGNOTTE H LESUR A LUPORSI E RODIER JF CUTULI B LASRY S MAURIAC L GRANON C KERR C GIARD S HILL C DELAFONTAN B DEGISLAIN C DANJOU J FONDRINIER E LEFEUVRE C LASSET C BONADONA V CHAUVIN F

Citation: H. Mignotte et al., ENDOMETRIAL CARCINOMA (EC) IN WOMEN WITH BREAST-CANCER (BC), European journal of cancer, 33, 1997, pp. 925-925

Authors: BAIN C MERROUCHE Y PUISIEUX I BLAY JY NEGRIER S BONADONA V LASSET C LANIER F DUC A GEBUHRER L PHILIP T FAVROT MC

Citation: C. Bain et al., CORRELATION BETWEEN CLINICAL-RESPONSE TO INTERLEUKIN-2 AND HLA PHENOTYPES IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA, British Journal of Cancer, 75(2), 1997, pp. 283-286